Prestige Biologics Co., Ltd.
A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.
334970 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 청주시 흥덕구 오송읍 오송생명1로 197, 청주시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Prestige Biologics Co., Ltd. is a global biopharmaceutical Contract Development and Engineering Manufacturing Organization (CDEMO) offering end-to-end solutions for the entire lifecycle of antibody-based therapeutics and other biologics. The company provides a full suite of services, from initial cell line and process development to analytical testing and manufacturing of drug substances and products for both clinical trials and commercial supply. Operating within GMP-compliant facilities, Prestige Biologics also supports clients with secondary packaging, logistics, and transportation for clinical trials, positioning itself as an integrated partner for biopharmaceutical innovators.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-19 00:00 |
Audit Report / Information
사업보고서 (2025.06)
|
Korean | 493.5 KB | ||
| 2025-09-18 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 18.5 KB | ||
| 2025-09-15 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
|
Korean | 176.8 KB | ||
| 2025-09-12 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
|
Korean | 25.6 KB | ||
| 2025-09-11 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 148.4 KB | ||
| 2025-09-11 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 20.3 KB | ||
| 2025-08-13 00:00 |
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 10.8 KB | ||
| 2025-07-31 00:00 |
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 13.4 KB | ||
| 2025-06-13 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.3 KB | ||
| 2025-06-04 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-05-26 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (바이오의약품 위탁생산 계약 진행의 건)
|
Korean | 8.3 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.0 MB | ||
| 2025-03-28 00:00 |
Post-Annual General Meeting Information
임시주주총회결과
|
Korean | 6.5 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
대표이사변경
|
Korean | 9.0 KB | ||
| 2025-03-17 00:00 |
Regulatory News Service
단일판매ㆍ공급계약체결
|
Korean | 10.1 KB |
Automate Your Workflow. Get a real-time feed of all Prestige Biologics Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Prestige Biologics Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
